# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001493152-22-026959
Filing Date
2022-09-28
Accepted
2022-09-28 08:00:31
Documents
43
Period of Report
2022-09-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form8-k.htm iXBRL | 8-K | 38955
2 |  | form8-k_001.jpg | GRAPHIC | 5687
3 |  | ex99-1.htm | EX-99.1 | 18934
4 |  | ex99-1_001.jpg | GRAPHIC | 47499
5 |  | ex99-1_002.jpg | GRAPHIC | 85053
6 |  | ex99-1_003.jpg | GRAPHIC | 78701
7 |  | ex99-1_004.jpg | GRAPHIC | 85124
8 |  | ex99-1_005.jpg | GRAPHIC | 70930
9 |  | ex99-1_006.jpg | GRAPHIC | 60157
10 |  | ex99-1_007.jpg | GRAPHIC | 46353
11 |  | ex99-1_008.jpg | GRAPHIC | 68555
12 |  | ex99-1_009.jpg | GRAPHIC | 54175
13 |  | ex99-1_010.jpg | GRAPHIC | 60771
14 |  | ex99-1_011.jpg | GRAPHIC | 52332
15 |  | ex99-1_012.jpg | GRAPHIC | 44254
16 |  | ex99-1_013.jpg | GRAPHIC | 72738
17 |  | ex99-1_014.jpg | GRAPHIC | 68706
18 |  | ex99-1_015.jpg | GRAPHIC | 83077
19 |  | ex99-1_016.jpg | GRAPHIC | 85657
20 |  | ex99-1_017.jpg | GRAPHIC | 83986
21 |  | ex99-1_018.jpg | GRAPHIC | 45634
22 |  | ex99-1_019.jpg | GRAPHIC | 84873
23 |  | ex99-1_020.jpg | GRAPHIC | 59905
24 |  | ex99-1_021.jpg | GRAPHIC | 44224
25 |  | ex99-1_022.jpg | GRAPHIC | 34281
26 |  | ex99-1_023.jpg | GRAPHIC | 65608
27 |  | ex99-1_024.jpg | GRAPHIC | 88675
28 |  | ex99-1_025.jpg | GRAPHIC | 44935
29 |  | ex99-1_026.jpg | GRAPHIC | 50626
30 |  | ex99-1_027.jpg | GRAPHIC | 58311
31 |  | ex99-1_028.jpg | GRAPHIC | 58024
32 |  | ex99-1_029.jpg | GRAPHIC | 78793
| Complete submission text file | 0001493152-22-026959.txt |  | 2813541

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
33 | INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | lpcn-20220928.xsd | EX-101.SCH | 3227
34 | INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | lpcn-20220928_lab.xml | EX-101.LAB | 34240
35 | INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | lpcn-20220928_pre.xml | EX-101.PRE | 22359
37 | EXTRACTED XBRL INSTANCE DOCUMENT | form8-k_htm.xml | XML | 3605

Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 221272813
SIC: 2834 Pharmaceutical Preparations